The Chief Executive Officer of the Ghana Investment Promotion Centre (GIPC), Mr Simon Madjie, has highlighted the critical role of technology transfer in enhancing innovation, transparency, and value addition in Ghana’s pharmaceutical sector.
Delivering the keynote address at a workshop on the Legal and Regulatory Framework for Technology Transfers in the Pharmaceutical Sector in Accra, Mr Madjie emphasized that technology transfer is vital for positioning Ghana as a competitive hub for pharmaceutical investment.
He noted that the GIPC is committed to strengthening its facilitation role through the establishment of a Technology Transfer Department and by deepening collaboration with key regulatory bodies to support investors and local industries.
According to Mr Madjie, effective technology transfer will drive local production capacity, improve research and development, and ensure sustainable growth in the pharmaceutical industry.
He reiterated that the Centre will continue to champion initiatives that align with the government’s vision for a 24-hour economy, ensuring that Ghana remains attractive to investors while building a globally competitive pharmaceutical sector.



Teachers, students killed in Thai school shooting near Bangkok
Social media giant Meta ordered to pay $567 million in New Mexico child safety r...
Bus explosion near Damascus kills at least two, injures 13
Trump signs order in new bid to curb birthright citizenship
Houthi rebels kill dozens of Saudi-backed Yemeni government forces
“Democracy Under Attack” demo: ‘We will seek God’s direction, not vengeance’ — H...
‘I have not seen anything from EOCO’ - Miracles Aboagye reacts to his ‘frozen as...
Democracy Under Attack demo: We must end the 'you do me, I do you' politics — Af...
“Democracy Under Attack” demo: Nominating presidential staffer to receive our pe...
'Don't underestimate NPP's comeback power' — Anthony Karbo tells NDC